We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.58%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.12B
AUM Growth
-$199M
(-3.7%)
Cap. Flow
-$200M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
24.54%
Holding
885
New
102
Increased
287
Reduced
309
Closed
94
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$25.9M |
| 2 |
Citizens Financial Group
CFG
|
+$23.8M |
| 3 |
EOG Resources
EOG
|
+$23.7M |
| 4 |
Independent Bank Group, Inc.
IBTX
|
+$18.4M |
| 5 |
Acuity Brands
AYI
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAV
B/E Aerospace Inc
BEAV
|
+$48.6M |
| 2 |
Ventas
VTR
|
+$42.2M |
| 3 |
Centene
CNC
|
+$38.9M |
| 4 |
Manhattan Associates
MANH
|
+$30.4M |
| 5 |
Salesforce
CRM
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.09% |
| 2 | Financials | 14.79% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 14.11% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Southern Copper
SCCO
$170B
| $1.7M | 0.03% |
58,256
-1,815
| -3% | -$50.5K |
2015 Q2
6 quarters
|
|
227
Fastenal
FAST
$57.8B
| $1.68M | 0.03% |
142,936
-22,012
| -13% | -$242K |
2013 Q2
14 quarters
|
|
228
Kimberly-Clark
KMB
$34.6B
| $1.68M | 0.03% |
14,711
-4,112
| -22% | -$477K |
2013 Q2
14 quarters
|
|
|
ALXN
229
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.63M | 0.03% |
13,356
-165
| -1% | -$20.2K |
2013 Q2
14 quarters
|
|
230
Walmart Inc
WMT
$935B
| $1.63M | 0.03% |
70,521
-7,638
| -10% | -$178K |
2013 Q2
14 quarters
|
|
|
WAGE
231
DELISTED
WageWorks, Inc.
WAGE
| $1.63M | 0.03% |
22,407
+1,195
| +6% | +$80.3K |
2015 Q4
4 quarters
|
|
|
KMPA
232
DELISTED
Kemper Corporation
KMPA
| $1.61M | 0.03% |
61,650
+2,550
| +4% | +$67.1K |
2014 Q1
11 quarters
|
|
233
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $1.6M | 0.03% |
48,410
+39,390
| +437% | +$1.25M |
2015 Q3
5 quarters
|
|
234
Five Below
FIVE
$12.3B
| $1.6M | 0.03% |
40,027
+12,486
| +45% | +$491K |
2015 Q4
4 quarters
|
|
|
MJN
235
DELISTED
Mead Johnson Nutrition Company
MJN
| $1.58M | 0.03% |
22,316
-3,587
| -14% | -$267K |
2013 Q2
14 quarters
|
|
236
T. Rowe Price
TROW
$21.6B
| $1.58M | 0.03% |
20,964
+543
| +3% | +$38.5K |
2013 Q2
14 quarters
|
|
237
Jefferies Financial Group
JEF
$10.3B
| $1.57M | 0.03% |
75,678
+690
| +0.9% | +$12.9K |
2013 Q2
14 quarters
|
|
238
DELISTED
Praxair Inc
PX
| $1.57M | 0.03% |
13,373
+822
| +7% | +$97.7K |
2013 Q2
14 quarters
|
|
239
Medtronic
MDT
$122B
| $1.56M | 0.03% |
21,974
-446
| -2% | -$35K |
2013 Q2
14 quarters
|
|
|
STMP
240
DELISTED
Stamps.com, Inc.
STMP
| $1.56M | 0.03% |
13,615
+969
| +8% | +$101K |
2015 Q4
4 quarters
|
|
241
MGM Resorts International
MGM
$7.42B
| $1.54M | 0.03% |
+53,576
| New | +$1.48M |
2016 Q4
0 quarters
|
|
242
Norfolk Southern
NSC
$73B
| $1.54M | 0.03% |
14,292
+539
| +4% | +$54.4K |
2013 Q2
14 quarters
|
|
243
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $1.54M | 0.03% |
40,983
+6,962
| +20% | +$248K |
2016 Q2
2 quarters
|
|
244
InterContinental Hotels
IHG
$24.3B
| $1.54M | 0.03% |
31,639
-3,341
| -10% | -$151K |
2014 Q4
8 quarters
|
|
245
DELISTED
INVESCO MORTGAGE CAPITAL INC. 7.75% Fixed-To-Floating Series B Cumulative Redeemable Preferred Stock
IVR.PRB
| $1.53M | 0.03% |
63,570
-1,090
| -2% | -$27.1K |
2014 Q3
9 quarters
|
|
|
RSPP
246
DELISTED
RSP Permian, Inc.
RSPP
| $1.53M | 0.03% |
34,291
+10,821
| +46% | +$448K |
2015 Q1
7 quarters
|
|
247
AGNC Investment
AGNC
$10.5B
| $1.52M | 0.03% |
84,129
+34,129
| +68% | +$647K |
2016 Q2
2 quarters
|
|
248
Ligand Pharmaceuticals
LGND
$5.95B
| $1.52M | 0.03% |
23,960
+1,359
| +6% | +$85.8K |
2016 Q1
3 quarters
|
|
|
EQM
249
DELISTED
EQM Midstream Partners, LP
EQM
| $1.5M | 0.03% |
19,597
-515
| -3% | -$38.2K |
2014 Q1
11 quarters
|
|
250
Omnicell
OMCL
$1.64B
| $1.5M | 0.03% |
44,276
+11,881
| +37% | +$409K |
2015 Q4
4 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, Geneva Advisors held 885 positions worth $5.12B, down 3.7% from $5.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors withdrew a net $200M in Q4 2016, closing 94 positions and reducing 309 holdings. Its most notable exit was Ventas, an estimated $42.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Geneva Advisors opened a new position in Citizens Financial Group worth $28M.
- Geneva Advisors's largest Q4 2016 buy was Citizens Financial Group: 786,703 shares worth $28M.
- Geneva Advisors added most to Celgene Corp in Q4 2016, an estimated $25.9M increase.
- Geneva Advisors's biggest Q4 2016 reduction was B/E Aerospace Inc, cutting an estimated $48.6M.
- Geneva Advisors fully exited Ventas in Q4 2016, selling an estimated $42.2M.
- Geneva Advisors's ten largest holdings make up 25% of its $5.12B portfolio in Q4 2016.
- Geneva Advisors opened 102 new positions and closed 94 in Q4 2016.
- Geneva Advisors's portfolio value fell 3.7% quarter-over-quarter to $5.12B.
Based on Geneva Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.